SportVis™ obtains the CE-mark
SportVis™ has been granted CE-mark under the classification of class III medical device by the Notify Body Kema Quality B.V.. SportVis™ relieves pain and optimises recovery of the ankle following 1st or 2nd degree sprain.
SportVis™ first clinical study publication
SportVis™ first randomised, double blind clinical study including 158 patients was published in the Clinical Journal of Sports Medicine. It demonstrated the efficacy of SportVis™ for treating acute grade 1 or 2 lateral ankle sprains, and showed a significant reduction in the time taken to return to pain-free and disability-free activity compared to the placebo group.
See the abstract.
MDT Int’l SA is incorporated in Geneva, Switzerland
MDT Int’l SA has been incorporated in The Registre du Commerce de Genève, Switzerland. MDT Int’l SA is dedicated to the development of medical devices used in a number of specialised therapeutic areas such as orthopaedic, soft tissue recovery.
Development and integration of an ISO Quality Management System (Q.M.S.)
Always keen to increase the quality of its products and to improve the relationship with its partners, MDT Int’l SA is setting up a Quality Management Sytem based on ISO 13485:2003 norm.
SportVis™ launched in three countries
MDT Int’l SA is proud to announce the launch of its first innovative class III medical device SportVis™ for reducing pain and optimising recovery of first and second degree ankle sprain in 3 European countries: Germany, Ireland and Greece. For more information, you can email us at: firstname.lastname@example.org.
SportVis™ launched in one additional country
MDT Int’l SA has been granted ISO 13485:2003 certification
MDT Int’l SA has undergone and passed the necessary audit conducted by KEMA Quality B.V. for ISO 13485:2003 certification. The original certificate was received on 4th August 2008 and will be valid to 1st July 2011.
New product receives CE Mark
A new patented & innovative orthopaedic product that will be commercialised by MDT Int’l SA in the next few months has been granted the CE Mark by the notified body “Kema Quality B.V”. The indication is "Solution for relief fo symptoms of osteoarthritis of the knee by providing support and lubrication to the knee."
If you would like more information about this product, please contact us at email@example.com.
RenehaVis™ at EULAR 2009
RenehaVis™ launched in 3 countries
RenehaVis™ is now available in Italy, Czech Republic and Turkey.
For more information on who your local distributor is, please click on contact us and leave us a message.
New Video - Real Life Practice Injection of Ankle
Video can be seen at the bottom of this page.
Congresses in June
MDT will be attending 2 congresses in June:
European Federation of National Associations of Orthopaedics and Traumatology
Location: Madrid, Spain
Date: 2nd to 5th June
European League Against Rheumatism
Date:16th to 19th June
Please make a prior appointment if you might like to speak to one of our representatives at the stand.
SEE YOU THERE!
New Video - Real Life Practice Injection of Elbow
Video showing the administration of SportVis™ in an elbow.
Publication of RenehaVis long term data (104 weeks)
More information can be found at RenehaVis website under the studies section.
SportVis™ and RenehaVis™ obtain Drug Tariff Listing in UK
The NHS Drug Tariff & Rules Team confirms that as of April 2012, both SportVis™ and RenehaVis™ will be included within Drug Tariff Part IX.
SportVis™ and RenehaVis™ in MIMS (UK)
MDT is proud to announce that both SportVis™ and RenehaVis™ are currently being on MIMS (UK) under section NEWS subsection NEW DRUGS.